The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
Investment demonstrates confidence in America’s commitment to science and innovation
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
Advances clinical research capabilities with leading regulatory grade registries platform
Chandy was the president of the Industrial Division of Pall Corporation, a leading supplier of filtration, separation, and purification technologies. Previously, she was chief marketing officer at the Dow Chemical Company and Rohm and Haas Corporation
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
Subscribe To Our Newsletter & Stay Updated
